Literature DB >> 20685937

Enterovirus 71 infection of monocytes with antibody-dependent enhancement.

Shih-Min Wang1, I-Chun Chen, Ling-Yao Su, Kao-Jean Huang, Huan-Yao Lei, Ching-Chuan Liu.   

Abstract

Enterovirus (EV) is an RNA virus that has circulated with different serotypes and genotypes worldwide. Enterovirus 71 (EV71) is a major neurotropic virus that causes severe brain stem encephalitis (BE) in infants and young children. The most vulnerable age for fatal infection is 6 to 11 months. This is associated with the coincident decline in maternal antibodies. The current report describes our finding that EV71 can infect human peripheral blood monocytes. We were able to show that EV71 infection is enhanced in the monocytic cell line THP-1 by the presence of subneutralizing concentrations of anti-EV71 antibodies. We also found that antibody-dependent enhancement (ADE) is mediated in part by Fcγ receptors. These observations support the concept that ADE augments the infectivity of EV71 for human monocytes and contributes to the age-dependent pathogenesis of EV71-induced disease. The ADE phenomenon must be considered during the development of an EV71 vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685937      PMCID: PMC2953001          DOI: 10.1128/CVI.00108-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  45 in total

1.  ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS.

Authors:  R A HAWKES
Journal:  Aust J Exp Biol Med Sci       Date:  1964-08

2.  Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells.

Authors:  Lien-Cheng Chen; Huey-Wen Shyu; Shun-Hua Chen; Huan-Yao Lei; Chun-Keung Yu; Trai-Ming Yeh
Journal:  J Med Virol       Date:  2006-06       Impact factor: 2.327

3.  Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.

Authors:  Takol Chareonsirisuthigul; Siripen Kalayanarooj; Sukathida Ubol
Journal:  J Gen Virol       Date:  2007-02       Impact factor: 3.891

4.  Deaths among children during an outbreak of hand, foot, and mouth disease--Taiwan, Republic of China, April-July 1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-08-07       Impact factor: 17.586

5.  Enterovirus receptors and virus replication in human leukocytes.

Authors:  T Vuorinen; R Vainionp; J Heino; T Hyypi
Journal:  J Gen Virol       Date:  1999-04       Impact factor: 3.891

Review 6.  Antibody-dependent enhancement of infection and the pathogenesis of viral disease.

Authors:  D M Morens
Journal:  Clin Infect Dis       Date:  1994-09       Impact factor: 9.079

7.  An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

Authors:  M Ho; E R Chen; K H Hsu; S J Twu; K T Chen; S F Tsai; J R Wang; S R Shih
Journal:  N Engl J Med       Date:  1999-09-23       Impact factor: 91.245

8.  Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications.

Authors:  S M Wang; C C Liu; H W Tseng; J R Wang; C C Huang; Y J Chen; Y J Yang; S J Lin; T F Yeh
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

9.  Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells.

Authors:  N A Fanger; K Wardwell; L Shen; T F Tedder; P M Guyre
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

10.  Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan.

Authors:  Chien-Min Kung; Chwan-Chuen King; Chun-Nan Lee; Li-Min Huang; Ping-Ing Lee; Chuan-Liang Kao
Journal:  J Med Virol       Date:  2007-01       Impact factor: 2.327

View more
  24 in total

1.  Construction and characterization of infectious cDNA clones of enterovirus 71 (EV71).

Authors:  Ying-Wei Ma; Shu-Bin Hao; Le-le Sun; Jing Li; Qiao Qiao; Feng Gao; Li Zhao; Xue-Jie Yu; Zhi-Yu Wang; Hong-Ling Wen
Journal:  Virol Sin       Date:  2015-08       Impact factor: 4.327

2.  EV71 infection correlates with viral IgG preexisting at pharyngo-laryngeal mucosa in children.

Authors:  Jingchang Xue; Yaoming Li; Xiaoyi Xu; Jie Yu; Hu Yan; Huimin Yan
Journal:  Virol Sin       Date:  2015-03-20       Impact factor: 4.327

3.  Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity.

Authors:  S-M Wang; T-S Ho; H-C Lin; H-Y Lei; J-R Wang; C-C Liu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-09       Impact factor: 3.267

4.  Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.

Authors:  Xiaoli Wang; Zhiqiang Ku; Xiang Zhang; Xiaohua Ye; Jinhuan Chen; Qingwei Liu; Wei Zhang; Chao Zhang; Zhenglin Fu; Xia Jin; Yao Cong; Zhong Huang
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

Review 5.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

6.  Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.

Authors:  I-Chun Chen; Shih-Min Wang; Chun-Keung Yu; Ching-Chuan Liu
Journal:  Med Microbiol Immunol       Date:  2013-02-14       Impact factor: 3.402

7.  Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study.

Authors:  Chonnamet Techasaensiri; Artit Wongsa; Thanyawee Puthanakit; Kulkanya Chokephaibulkit; Tawee Chotpitayasunondh; Ubonwon Charoonruangrit; Somjai Sombatnimitsakul; Pilaipan Puthavathana; Hatairat Lerdsamran; Prasert Auewarakul; Boonrat Tassaneetrithep
Journal:  Pathogens       Date:  2021-05-19

8.  Pathological Features of Enterovirus 71-Associated Brain and Lung Damage in Mice Based on Quantitative Proteomic Analysis.

Authors:  Yuefei Jin; Dong Li; Tiantian Sun; Yue Du; Yanlei Gao; Ronghua Ding; Wangquan Ji; Weiguo Zhang; Haiyan Yang; Shuaiyin Chen; Guangcai Duan
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

9.  Immunological evaluation and comparison of different EV71 vaccine candidates.

Authors:  Ai-Hsiang Chou; Chia-Chyi Liu; Jui-Yuan Chang; Shu-Pei Lien; Meng-Shin Guo; Hau-Pong Tasi; Kuang-Nan Hsiao; Shih-Jen Liu; Charles Sia; Suh-Chin Wu; Min-Shi Lee; Chia-Hsin Hsiao; Jen-Ren Wang; Yen-Hung Chow; Pele Chong
Journal:  Clin Dev Immunol       Date:  2012-09-12

10.  Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection.

Authors:  Rui-Yuan Cao; Da-Yong Dong; Rui-Ju Liu; Jian-Feng Han; Guang-Chuan Wang; Hui Zhao; Xiao-Feng Li; Yong-Qiang Deng; Shun-Ya Zhu; Xiao-Yu Wang; Fang Lin; Fu-Jun Zhang; Wei Chen; E-De Qin; Cheng-Feng Qin
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.